These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28528082)

  • 21. Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitor.
    Gibbs JP; Emery MG; McCaffery I; Smith B; Gibbs MA; Akrami A; Rossi J; Paweletz K; Gastonguay MR; Bautista E; Wang M; Perfetti R; Daniels O
    J Clin Pharmacol; 2011 Jun; 51(6):830-41. PubMed ID: 20663992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design.
    Tice CM; Zhao W; Xu Z; Cacatian ST; Simpson RD; Ye YJ; Singh SB; McKeever BM; Lindblom P; Guo J; Krosky PM; Kruk BA; Berbaum J; Harrison RK; Johnson JJ; Bukhtiyarov Y; Panemangalore R; Scott BB; Zhao Y; Bruno JG; Zhuang L; McGeehan GM; He W; Claremon DA
    Bioorg Med Chem Lett; 2010 Feb; 20(3):881-6. PubMed ID: 20064717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-(S)-phenethylaminothiazolones as potent, orally efficacious inhibitors of 11beta-hydroxysteriod dehydrogenase type 1.
    Jean DJ; Yuan C; Bercot EA; Cupples R; Chen M; Fretland J; Hale C; Hungate RW; Komorowski R; Veniant M; Wang M; Zhang X; Fotsch C
    J Med Chem; 2007 Feb; 50(3):429-32. PubMed ID: 17266194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
    Nakano S; Inada Y; Masuzaki H; Tanaka T; Yasue S; Ishii T; Arai N; Ebihara K; Hosoda K; Maruyama K; Yamazaki Y; Shibata N; Nakao K
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a potent, selective, and orally bioavailable acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017).
    Scott JS; Bowker SS; Deschoolmeester J; Gerhardt S; Hargreaves D; Kilgour E; Lloyd A; Mayers RM; McCoull W; Newcombe NJ; Ogg D; Packer MJ; Rees A; Revill J; Schofield P; Selmi N; Swales JG; Whittamore PR
    J Med Chem; 2012 Jun; 55(12):5951-64. PubMed ID: 22691057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors.
    Sun D; Wang Z; Caille S; DeGraffenreid M; Gonzalez-Lopez de Turiso F; Hungate R; Jaen JC; Jiang B; Julian LD; Kelly R; McMinn DL; Kaizerman J; Rew Y; Sudom A; Tu H; Ursu S; Walker N; Willcockson M; Yan X; Ye Q; Powers JP
    Bioorg Med Chem Lett; 2011 Jan; 21(1):405-10. PubMed ID: 21093258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
    Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
    Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
    Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA
    Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
    Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and optimization of picolinamide derivatives as a novel class of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors.
    Ryu JH; Kim S; Lee JA; Han HY; Son HJ; Lee HJ; Kim YH; Kim JS; Park HG
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1679-1683. PubMed ID: 25800116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitors.
    McMinn DL; Rew Y; Sudom A; Caille S; Degraffenreid M; He X; Hungate R; Jiang B; Jaen J; Julian LD; Kaizerman J; Novak P; Sun D; Tu H; Ursu S; Walker NP; Yan X; Ye Q; Wang Z; Powers JP
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1446-50. PubMed ID: 19185488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1).
    Sun D; Wang Z; Cardozo M; Choi R; Degraffenreid M; Di Y; He X; Jaen JC; Labelle M; Liu J; Ma J; Miao S; Sudom A; Tang L; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1522-7. PubMed ID: 19181519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cyclicsulfonamide derivatives with an acetamide group as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
    Kim SH; Kwon SW; Chu SY; Lee JH; Narsaiah B; Kim CH; Kang SK; Kang NS; Rhee SD; Bae MA; Ahn SH; Ha DC; Kim KY; Ahn JH
    Chem Pharm Bull (Tokyo); 2011; 59(1):46-52. PubMed ID: 21212546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
    Yang H; Dou W; Lou J; Leng Y; Shen J
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
    Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
    Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group.
    Kwon SW; Kang SK; Lee JH; Bok JH; Kim CH; Dal Rhee S; Jung WH; Kim HY; Bae MA; Song JS; Ha DC; Cheon HG; Kim KY; Ahn JH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):435-9. PubMed ID: 21093259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1).
    Sun D; Wang Z; Di Y; Jaen JC; Labelle M; Ma J; Miao S; Sudom A; Tang L; Tomooka CS; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3513-6. PubMed ID: 18511278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
    Lin H; Hu GX; Guo J; Ge Y; Liang G; Lian QQ; Chu Y; Yuan X; Huang P; Ge RS
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4362-6. PubMed ID: 23800686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™).
    Webster SP; McBride A; Binnie M; Sooy K; Seckl JR; Andrew R; Pallin TD; Hunt HJ; Perrior TR; Ruffles VS; Ketelbey JW; Boyd A; Walker BR
    Br J Pharmacol; 2017 Mar; 174(5):396-408. PubMed ID: 28012176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1.
    Xia G; Liu L; Xue M; Liu H; Yu J; Li P; Chen Q; Xiong B; Liu X; Shen J
    Mol Cell Endocrinol; 2012 Jul; 358(1):46-52. PubMed ID: 22410288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.